| Product Code: ETC12838543 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In the Indonesia influenza medications market, the import trend showed significant growth from 2023 to 2024, with a growth rate of 28.57%. The compound annual growth rate (CAGR) for the period 2020-2024 stood at 108.01%. This surge in imports can be attributed to a notable shift in demand for influenza medications, indicating a heightened market stability and increased reliance on imported products to meet the market demand.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Influenza Medications Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Indonesia Influenza Medications Market - Industry Life Cycle |
3.4 Indonesia Influenza Medications Market - Porter's Five Forces |
3.5 Indonesia Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Indonesia Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Indonesia Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Indonesia Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of early treatment of influenza |
4.2.2 Rising incidence of influenza cases in Indonesia |
4.2.3 Government initiatives to improve healthcare infrastructure and access |
4.3 Market Restraints |
4.3.1 High cost of influenza medications |
4.3.2 Presence of counterfeit or substandard influenza medications in the market |
4.3.3 Limited availability of advanced treatment options for severe cases |
5 Indonesia Influenza Medications Market Trends |
6 Indonesia Influenza Medications Market, By Types |
6.1 Indonesia Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Indonesia Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Indonesia Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Indonesia Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Indonesia Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Indonesia Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Indonesia Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Indonesia Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Indonesia Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Indonesia Influenza Medications Market Import-Export Trade Statistics |
7.1 Indonesia Influenza Medications Market Export to Major Countries |
7.2 Indonesia Influenza Medications Market Imports from Major Countries |
8 Indonesia Influenza Medications Market Key Performance Indicators |
8.1 Number of influenza cases diagnosed annually |
8.2 Percentage of population vaccinated against influenza |
8.3 Average time from symptom onset to treatment initiation |
9 Indonesia Influenza Medications Market - Opportunity Assessment |
9.1 Indonesia Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Indonesia Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Indonesia Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Indonesia Influenza Medications Market - Competitive Landscape |
10.1 Indonesia Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Indonesia Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here